| Bioactivity | Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed via degradation of erythromycin in acidic aqueous solutions in vitro as well as in vivo. Anhydroerythromycin A is active against S. aureus and B. cereus in vitro (MICs = 12.5 and 6.25 μg/ml, respectively). Anhydroerythromycin A also inhibits steroid 6β-hydroxylase activity associated with the cytochrome P450 (CYP) isoform CYP3A in human liver microsomes. |
| Name | Anhydroerythromycin A |
| CAS | 23893-13-2 |
| Formula | C37H65NO12 |
| Molar Mass | 715.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Anhydroerythromycin A
CAS: 23893-13-2 F: C37H65NO12 W: 715.91
Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.